Please assess the completion status of the following clinical trial:

Trial Title: Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of Spiriva

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion:~* diagnosis of COPD~* FEV1 \< 60% of predicted~* FEV1 \< 70% of FVC~* smoking history of 10 pack-years~Exclusion:~* significant other disease than COPD~* history of asthma, allergic rhinitis or blood eosinophil count \> 600mm3~* cardiac arrhythmia requiring drug therapy~* symptomatic prostatic hypertrophy, bladder neck obstruction or narrow-angle glaucoma~* recent history of MI (within past year)~* history of cancer within past 5 years~* life-threatening pulmonary obstruction~* cystic fibrosis or bronchiectasis; tuberculosis~* pulmonary resection

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).